Two-year radiographic and clinical outcomes from the Canadian Methotrexate and Etanercept Outcome study in patients with rheumatoid arthritis

Objective. To evaluate radiographic and clinical outcomes up to 24 months in patients with RA enrolled in the Canadian Methotrexate and Etanercept Outcome study. Methods. In this open-label non-inferiority trial, patients with inadequate response to MTX received etanercept plus MTX for 6 months and...

Descripción completa

Detalles Bibliográficos
Autores principales: Keystone, Edward C., Pope, Janet E., Thorne, J. Carter, Poulin-Costello, Melanie, Phan-Chronis, Krystene, Vieira, Andrew, Haraoui, Boulos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710802/
https://www.ncbi.nlm.nih.gov/pubmed/26361879
http://dx.doi.org/10.1093/rheumatology/kev338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710802/
https://www.ncbi.nlm.nih.gov/pubmed/26361879
http://dx.doi.org/10.1093/rheumatology/kev338

Ejemplares similares